PHARMAKON A/S: Financial statements 2023
CVR: 10038839
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
PHARMAKON A/S (CVR 10038839) has filed annual accounts for 2023. In 2023, the company reported revenue of DKK 140,527,000 and a net result of DKK 5,100,000 compared with DKK 2,732,000 the year before. That is an increase of 9% compared with the year before. The profit margin was 3.6%. Equity in the 2023 report amounted to DKK 99,965,000. The solvency ratio was 79%. The company had 131 employees in the financial year.
- Revenue
- DKK 140,527,000
- Profit/Loss
- DKK 5,100,000
- Equity
- DKK 99,965,000
- Total Assets
- DKK 126,486,000
- Employees
- 131
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | 140.5M | - | 5.1M | 100M | 131 |
| 2022 | 128.9M | - | 2.7M | 94.9M | 129 |
| 2021 | 117.1M | - | 8.3M | 92.1M | 120 |
| 2020 | 107.6M | - | 2.4M | 83.9M | 127 |
| 2019 | 120.2M | - | 1.9M | 81.5M | 128 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of May 31, 2023, Birgitte Malene Margrethe Nørfelt Grøn has left the board of directors of PHARMAKON A/S.
PHARMAKON A/S has published its annual report for 2022. Revenue came to DKK 128,937,000, and the net result was DKK 2,732,000.
About PHARMAKON A/S
PHARMAKON A/S is a Danish company of the type Aktieselskab based in Hillerød, founded in 1986. The company is registered under the industry Drift af hoteller og lignende overnatningsfaciliteter. The company was previously named DANMARKS APOTEKERFORENINGS KURSUSEJENDOM A/S. The management consists of Lotte Fonnesbæk. The board consists of Lars Pram Olsen (chair), Anja Claudia Hoffmann, Ditte Poulsen and Jeanette Hovgaard Rasmussen. The company is owned by D.A. INVEST OG UDVIKLING A/S. The company has 170 employees (2026). In 2025, the company reported revenue of DKK 143,466,000 and a net result of DKK -3,206,000 compared with DKK 1,890,000 the year before. Equity in the 2025 report amounted to DKK 98,649,000.